Research Summary: Medication Safety, MTMS, Pharmacogenomics Education
Dr. Kuo and her research team evaluate medication safety practices at the system, provider, and patient levels in the primary care setting. She has conducted research projects to 1) evaluate effects of electronic medical records on medication safety; 2) implement best practices for safe use of medications in primary care practices; 3) assess effects of patients' health literacy on medication safety; 4) analyze types of medication errors reported by clinicians; and 5) measure safety cultures in practices.
Collaborating with physicians and pharmacists, Dr. Kuo has helped to design, implement, and evaluate medication therapy management services (MTMS) for chronic diseases such as diabetes, heart disease, mental health, anticoagulation, and asthma.
Dr. Kuo is the Program Director for PharmGenEd™, a pharmacogenomics education program that strives to educate clinicians and students about concepts and clinical applications of pharmacogenomics.
Dr. Kuo is also the Director of SDPharmNet™, where pharmacists from various practice settings are collaborating to provide the best practices, tools and resources for pharmaceutical care and medication therapy management services
Education: B.S. in Psychobiology (1985) UCLA; B.S. in Pharmacy (1988) Massachusetts College of Pharmacy and Allied Health Sciences; Pharm.D. (1998) OSU College of Pharmacy and OHSU School of Medicine; Specialized Residency in Primary Care (1998-1999) NIH Clinical Center; M.P.H. (2005) UTHS-Houston School of Public Health; Ph.D. (2011) UTHS-Houston School of Public Health.
B.S. in Psychobiology (1985) UCLA; B.S. in Pharmacy (1988) Massachusetts College of Pharmacy and Allied Health Sciences; Pharm.D. (1998) OSU College of Pharmacy and OHSU School of Medicine; Specialized Residency in Primary Care (1998-1999) NIH Clinical Center; M.P.H. (2005) UTHS-Houston School of Public Health; Ph.D. (2011) UTHS-Houston School of Public Health.
Awards and Honors: TSHP Lewis S. Smith Pharmacy Practitioner Award (2002); ASHP Foundation Literature Award for Innovation in Pharmacy Practice in Health Systems (2005); AHRQ Mentored Clinical Scientist Career Development Award (2005-2010); ACCP-Southern California Chapter Research Award (2010); Member of Delta Omega National Honorary Society in Public Health (2011); ACCP Fellow (2011); Asian Heritage Award in health and Medicine (2012).
Leadership Experience: Program Director of SPUR-Net; (2001-2007); Director of SDPharmNet; (2008-present); Program Director of PharmGenEd (2009-present); Director of ACCP PBRN (2009-2010); Council of Chairs (2013-present); Chair of UCSD AHPEC Committee (2013-present).
Key Contributions to Pharmaceutical Sciences
Improved medication safety through practice-based translational research.
Established physician and pharmacist collaborative practice for medication therapy management with reimbursement models in primary care clinics.
Disseminated pharmacogenomics information to clinicians and students.
Pioneered formation of regional and national practice-based research networks for pharmacists and physicians.
Kuo et al. (2008). Medication errors reported by U.S. family physicians and their office staff. Qual Saf Health Care 17:286-290.
Marinac et al. (2010). Characterizing the American College of Clinical Pharmacy Practice-Based Research Network. Pharmacotherapy 30:264e-273e.
Kuo GM et al (2011). Institutional Profile: University of California San Diego Pharmacogenomics Education Program (PharmGenEd™): bridging the gap between science and practice. Pharmacogenomics 12:149-53.
Kuo GM et al. (2013). Drug Errors and Related Interventions Reported by US Clinical Pharmacists: the ACCP PBRN MEDAP Study. Pharmacotherapy 33:253-65.
Kuo GM et al. (2013). Implementation and outcomes of a live continuing education program on pharmacogenomics. Pharmacogenomics 14:885-95.
Back to Contact List